NICE underlines recommendation for Servier's Procoralan in heart failure
This article was originally published in Scrip
Executive Summary
NICE, the health technology appraisal institute for England and Wales, has reaffirmed its earlier decision on Servier's Procoralan (ivabradine), recommending the product as a treatment option for some people with chronic heart failure in its final draft guidance.